STARTUP PROFILE

Sabi

COUNTRY
USA
FOUNDED
2023
CATEGORY
Consumer Neurotech
Developing a non-invasive EEG cap that aims to translate internal speech and mental commands into computer input.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Seed
MODALITY
EEG
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Wellness
TARGET USER
Consumers
REGULATORY STAGE
Non-medical
Sabi sits in the consumer BCI segment, with its core bet centered on high-density non-invasive EEG and imagined-speech decoding as an input layer for everyday computing. Its positioning is differentiated by the ambition to move EEG from passive state monitoring toward active command generation, placing it closer to interface infrastructure than conventional consumer neurofeedback.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
11
BCI reaches a new scale
30 September – 13 October 2026

Sabi raised a $50M seed round led by Khosla Ventures, with Accel and DST Global participating, to develop an EEG-equipped cap for decoding imagined speech. The company claims it built a foundation model trained on over 100,000 hours of recordings and that it now reaches 30 words per minute at up to 77% accuracy using a wired lab prototype. No peer-reviewed results or accuracy methodology have been published. An early wearable prototype is expected at CES 2027.

Articles featuring
Sabi